Russell Frank Company’s Meridian Bioscience Inc VIVO Stock Holding History

Russell Frank Company’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$1.79M	Buy	86,948 +64,753	+292%	+$1.28M	﹤0.01%	1905
2015 Q4	$466K	Buy	22,195 +17,383	+361%	+$333K	﹤0.01%	2504
2015 Q3	$82K	Buy	+4,812	New	+$87.9K	﹤0.01%	2850
2014 Q4	–	Sell	-8,081	Closed	-$143K	–	3055
2014 Q3	$143K	Sell	8,081 -15,035	-65%	-$295K	﹤0.01%	2599
2014 Q2	$463K	Sell	23,116 -36,595	-61%	-$752K	﹤0.01%	2344
2014 Q1	$1.3M	Sell	59,711 -18,684	-24%	-$428K	﹤0.01%	1968
2013 Q4	$1.79M	Sell	78,395 -176,342	-69%	-$4.33M	﹤0.01%	1791
2013 Q3	$6.02M	Sell	254,737 -194,331	-43%	-$4.54M	0.01%	1206
2013 Q2	$9.66M	Buy	+449,068	New	+$9.68M	0.02%	872

Other funds holding VIVO

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Russell Frank Company's VIVO Position: Q1 2016 in Review

Russell Frank Company increased its Meridian Bioscience Inc (VIVO) stake by 292% in Q1 2016, buying an estimated $1.28M and bringing the position to 86,948 shares worth $1.79M. The position accounts for ﹤0.01% of the portfolio, ranked #1905.

Russell Frank Company first reported a position in VIVO in Q2 2013 and has held it in 9 quarters since. The position peaked at $9.66M in Q2 2013. 172 funds tracked by Wall St. Rank hold VIVO as of Q1 2016.

Russell Frank Company held 86,948 shares of Meridian Bioscience Inc worth $1.79M as of Q1 2016.
Russell Frank Company bought 64,753 Meridian Bioscience Inc shares in Q1 2016, an estimated $1.28M.
Meridian Bioscience Inc made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #1905 holding.
Russell Frank Company first reported a position in Meridian Bioscience Inc in Q2 2013 and has held it in 9 quarters since.
Russell Frank Company's Meridian Bioscience Inc position peaked at $9.66M in Q2 2013.
172 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.